Lyka Labs Ltd. — Regulatory Filings 2022

Jan 4, 2022

Phone: 2363 4926 / 2363 0306

04th January, 2022

BSE Ltd	National Stock Exchange of India Ltd
1st floor, New Trading Ring	Exchange Plaza, 5 th Floor
Rotunda Bldg., P.J. Towers, Dalal Street, Mumbai - 400 001	Plot No. C/1, G. Block
	Bandra Kurla Complex
	Bandra (East), Mumbai - 400 051
Script Code: 500259	Script Code: LYKALABS

Dear Sir/Madam,

Sub: Disclosure under Reg. 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011

I, Kunal Narendra Gandhi, file herewith Disclosure under Regulation 31(1) & 31(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011; for release of pledge of 12,000 Equity Shares held in Lyka Labs Limited.

I request you to take the disclosure on your record.

Thanking you, Yours Faithfully,

(Kunal N. Gandhi) Promoter/ Promoter Group

Encl. a/a

$CC$ To, Piyush G. Hindia Company Secretary & Compliance Officer, Lyka Labs Limited 4801/B & 4802/A, GIDC, Industrial Estate, Ankleshwar-393 002

Disclosure by the Promoter(s) to the stock exchanges and to the Target Company for encumbrance of shares/invocation of encumbrance/release of in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Share LYKA LABS LIMITED Name of the Target Company (TC) BSE LTD Names of the stock exchanges where the shares of the target company are listed NATIONAL STOCK EXCHANGE OF INDIA LIMITED 04/01/2022 Date of Reporting Kunal Narendra Gandhi Name of the Promoter or PCA on whose shares encumbrance has been created/invoked/released Details of the release of encumbrance: Post event holding encumbered shares { creation [(2)+(3)]/ Promotor holding Promotor holding in the Details of events pertaining to encumbrance (3) release [(2)-(3)]/ invocation [(1)already encumbered Name of the promoter (s) or PACs with him * target company (1) $(3)]$ $(2)$ Type of encumbrance (pledge/lien/ % of Type of event Name of the entity in $%$ of non disposal Date of total (creation/ % of total % of total share whose favour shares creation/release/invocatio undertaking/ Reasons for encumbrance share share release/ share capital encumbered *** Number Number $\ast$ capital others) n of encumbrance capital invocation) Number capital Number $\mathbf{o}$ $\mathbf 0$ -93 溢 S. $\sim$ $\sim$ $\bf{0}$ $\mathbf{0}$ $\mathcal{L}_{\mathcal{L}}$ $\overline{\phantom{a}}$ 4.88 1400776 Narendra I Gandhi (HUF) 533200 1.86 $\sim$ Page $\sim$ 4.07 533200 1.86 $\blacksquare$ $\sim$ 1167629 Narendra I Gandhi 1.30 373415 $\overline{\phantom{a}}$ $\sim$ $\bullet$ $\sim$ - 2 373415 1.30 $\overline{\phantom{a}}$ 1157453 4.03 $\bullet$ Nehal N. Gandhi $0.24$ 70000 $0.04$ Ajit Shah Repayment of Loan 12000 31/12/2021 Pledge $0.29$ Release 82000 3.55 1018376 Kunal N. Gandhi $\mathbf 0$ 0 $\overline{a}$ $\sim$ $\sim$ $\mathcal{L}$ $\overline{\phantom{a}}$ 3.46 $\bf{0}$ $\mathbf{o}$ $\sim$ a. 993827 Enai Trading and Investment Private Limited $\mathbf 0$ 0 $\sim$ $\sim$ $\sim$ $\mathbf 0$ $\overline{\phantom{a}}$ 12100 $0.04$ $\mathbf{o}$ om. Lyka Animal Healthcare Limited

Signature of the Authorised Signatory

Place Mumbai Date 04/01/2022 Kunal N. Gandhi

(*) The names of all the promoters, their shareholding in the target company and their pledged share holding as on the reporting date should appear in the table irrespective of whatever they are reporting on the date of ev

(**)For example, for the purpose of collateral for loans taken by the Company, personal borrowing, third party pledge, etc (***) This would include the name of both the lender and the trustee who may hold shares directly or on behalf of the lender